Dave Gardner
Fortune : 912 161 $ au 31/05/2026
Fortune : 912 161 $ au 31/05/2026
Dave Gardner is Chief Strategy Officer & Executive Vice President at Incyte Corp.
since 2025.
Former roles include Director at Xilio Therapeutics, Inc., Vice President at BlackRock Finance, Inc. from 2006 to 2015, and Analyst at Rock Springs Capital Management LP from 2015 to 2025.
Education includes an MBA from Columbia Business School conferred in 2015 and an undergraduate degree from McIntire School of Commerce.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/09/2025 | 9 429 ( 0 % ) | 912 161 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 22/09/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Rock Springs Capital Management LP
Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Analyst-Equity | 01/09/2025 |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Corporate Officer/Principal | 01/05/2015 |
| XILIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Finance |
Rock Springs Capital Management LP
Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Finance |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McIntire School of Commerce
McIntire School of Commerce Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national